NexImmune, Inc. announced unaudited earnings results for the first quarter ended March 31, 2021. For the quarter, the company announced loss from operations of $10,070,200 compared to $6,360,568 a year ago. Net loss was $8,546,551 compared to $6,315,508 a year ago. Basic and diluted net loss available to common stockholders per common share was $0.71 compared to $5.68 a year ago.